Pimobendan (INN, or pimobendane), sold under the brand name Vetmedin among others, is a veterinary medication. It is a calcium sensitizer and a selective...
14 KB (1,266 words) - 16:40, 23 September 2024
solution) was conditionally approved for use with concurrent therapy with pimobendan, spironolactone, and an angiotensin-converting enzyme (ACE) inhibitor...
11 KB (1,026 words) - 05:17, 27 October 2024
– animal euthanasia product containing phenytoin and pentobarbital pimobendan – phosphodiesterase 3 inhibitor used to manage heart failure in dogs pirlimycin...
11 KB (1,144 words) - 12:20, 8 August 2024
Ensifentrine Imazodan KMUP-1 Meribendan Milrinone Olprinone Parogrelil Pimobendan Pumafentrine Quazinone RPL-554 Siguazodan Trequinsin Vesnarinone Zardaverine...
35 KB (3,243 words) - 04:46, 27 October 2024
hydrochloride Pentifylline Pentoxifylline Perbufylline Piclamilast Pimefylline Pimobendan Piroximone Prinoxodan Proxyphylline Pumafentrine Quazinone Quazodine Revamilast...
2 KB (137 words) - 00:17, 9 February 2024
Anagrelide Cilostazol is used in the treatment of intermittent claudication. Pimobendan is FDA approved for veterinary use in the treatment of heart failure in...
22 KB (2,350 words) - 08:18, 3 June 2024
Ensifentrine Imazodan KMUP-1 Meribendan Milrinone Olprinone Parogrelil Pimobendan Pumafentrine Quazinone RPL-554 Siguazodan Trequinsin Vesnarinone Zardaverine...
18 KB (1,888 words) - 18:19, 23 October 2024
inhibitors include the following: amrinone cilostazol milrinone enoximone pimobendan (approved for human use in Japan, approved for dogs elsewhere) PDE3 inhibitors...
11 KB (1,218 words) - 16:32, 19 October 2024
Ensifentrine Imazodan KMUP-1 Meribendan Milrinone Olprinone Parogrelil Pimobendan Pumafentrine Quazinone RPL-554 Siguazodan Trequinsin Vesnarinone Zardaverine...
24 KB (2,290 words) - 12:25, 6 November 2024
blood volume, and ACE inhibitors, which interrupt the RAAS. Recently, pimobendan – which increases the force with which the heart muscle contracts, and...
68 KB (8,040 words) - 02:48, 19 August 2024